TrialGut2022

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.

Geltrude Mingrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.